SCHEMBL4314727

SCHEMBL4314727

CC1=Cc2c(sc3cccc(-c4ccccc4)c23)C1[Si](C)(C)C1C(C)=Cc2c1sc1cccc(-c3ccccc3)c21

nearest known ligand 0.39

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
LIMK1 P53667 2/20 0.39
PLK4 O00444 1/20 0.31
MAPK9 P45984 1/20 0.31
CLK4 Q9HAZ1 1/20 0.31
AKT3 Q9Y243 1/20 0.31
F9 P00740 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1454376 0.74 ALDH1A1 (0.40) MAPK9CLK4
SCHEMBL29366427 0.74 PDCD1 (0.34)
SCHEMBL61908 0.74 PDCD1 (0.34)
Hydrochloric Acid SCHEMBL3822639 0.71 ADRA2A (0.34)
SCHEMBL6056122 0.71 PDCD1 (0.30)
SCHEMBL14448392 0.71
Dimethylamine SCHEMBL1453283 0.70 TDO2 (0.33)
SCHEMBL7050759 0.69 PDCD1 (0.35)
SCHEMBL6781256 0.69 BRD4 (0.33)
SCHEMBL1452295 0.69 PDCD1 (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1680453-B1 ORGANOMETALLIC TRANSITION METAL COMPOUND, BISCYCLOPENTADIENYL LIGAND SYSTEM, CATALYST SYSTEM AND PROCESS FOR PREPARING POLYOLEFINS BASELL POLYOLEFINE GMBH (DE) 2012-08-15 EP disclosed
US-7504354-B2 Organometallic transition metal compound, biscyclopentadienyl ligand system, catalyst system and process for preparing polyolefins BASELL POLYOLEFINE GMBH (DE) 2009-03-17 US disclosed
US-20070260025-A1 Organometallic Transition Metal Compound, Biscyclopentadienyl Ligand System, Catalyst System and Process for Preparing Polyolefins BASELL POLYOLEFINE GMBH (DE) 2007-11-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070260025-A1 Organometallic Transition Metal Compound, Biscyclopentadienyl Ligand System, Catalyst System and Process for Preparing Polyolefins SOD3, SOD1, MRPS23 LIMK1 2581/4885PLK4 1554/4885MAPK9 3797/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.